Screener
Harmony Biosciences Holdings, Inc. HRMY Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Sales and marketing | 31,694 | 30,711 |
| General and administrative | 32,507 | 31,243 |
| Total operating expenses | 133,584 | 96,494 |
| Operating income | 37,291 | 56,245 |
| Other expense, net | (127) | (276) |
| Interest expense | (3,234) | (3,836) |
| Interest income | 5,757 | 5,044 |
| Income before income taxes | 39,687 | 57,177 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s operating income?
- Harmony Biosciences Holdings, Inc. (HRMY) reported operating income of $37.29M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s operating income changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s operating income decreased by 33.7% year-over-year, from $56.25M to $37.29M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s operating income?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s operating income has grown at a 24.2% compound annual growth rate (CAGR), from $87.53M to $208.47M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Harmony Biosciences Holdings, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude